Presentation is loading. Please wait.

Presentation is loading. Please wait.

Half-life of removal from subcutaneous administration site after subcutaneous administration of fluorescence-labeled VEGF-C156S, ovalbumin (OVA), bovine.

Similar presentations


Presentation on theme: "Half-life of removal from subcutaneous administration site after subcutaneous administration of fluorescence-labeled VEGF-C156S, ovalbumin (OVA), bovine."— Presentation transcript:

1 Half-life of removal from subcutaneous administration site after subcutaneous administration of fluorescence-labeled VEGF-C156S, ovalbumin (OVA), bovine serum albumin (BSA), and bevacizumab in mice (data from Wu et al., 2012). Half-life of removal from subcutaneous administration site after subcutaneous administration of fluorescence-labeled VEGF-C156S, ovalbumin (OVA), bovine serum albumin (BSA), and bevacizumab in mice (data from Wu et al., 2012). Wolfgang F. Richter, and Björn Jacobsen Drug Metab Dispos 2014;42: Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics


Download ppt "Half-life of removal from subcutaneous administration site after subcutaneous administration of fluorescence-labeled VEGF-C156S, ovalbumin (OVA), bovine."

Similar presentations


Ads by Google